jolkinolide b has been researched along with B16 Melanoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gao, C; Han, J; Li, D; Wang, B; Yan, X; Yu, L; Zheng, Q | 1 |
1 other study(ies) available for jolkinolide b and B16 Melanoma
Article | Year |
---|---|
Jolkinolide B induces apoptosis and inhibits tumor growth in mouse melanoma B16F10 cells by altering glycolysis.
Topics: Adenosine Triphosphate; Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Caspase 9; Cell Line, Tumor; Cell Proliferation; Diterpenes; Down-Regulation; Euphorbia; Glucose Transporter Type 1; Glucose Transporter Type 3; Glucose Transporter Type 4; Glycolysis; Hexokinase; Melanoma, Experimental; Membrane Potential, Mitochondrial; Mice; Mice, Inbred C57BL; Mitochondria; Plant Roots; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Transplantation, Homologous | 2016 |